#abval16
2nd International
Antibody Validation Meeting
- University of Bath
- 15/09/16 - 16/09/16
- 12 Speakers
In September of 2016 we had the pleasure of welcoming delegates to the Second International Antibody Validation Meeting.
The event attracted nearly 100 attendees, coming from all over the world to bring together ideas and expertise, and to take part in conversation aimed at establishing best practices in research antibody validation and improving antibody validation for the life science community.
The talks
Alison Banham (University of Oxford)
The EuroMabNet approach to antibody validation and strategies for validating T-cell receptor mimic antibodies.
Deepa Shankar (Thermo Fisher Scientific)
Affinity reagents engineered for reproducibility with demonstrated specificity and Sensitivity.
Lars Björk (Human Protein Atlas)
Application specific antibody validation. The Human Protein Atlas and how to confirm subcellular protein localization.
Alejandra Solache (Abcam)
Mike Taussig (Cambridge Protein Arrays)
Proteome-wide Protein Microarrays: Techniques and Applications.
Jason Li (Proteintech)
Transparency: the ultimate validation of antibodies for research.
Arthur Lewis (Medimunne)
Validation of Antibodies for Immunohistochemistry: The importance to the drug discovery process.
Birte Aggeler (Bio-Techne/R&D)
Antibody validation: Many methods for one Answer.
Karine Enesa (Astra Zeneca)
AstraZeneca antibody generation and validation capabilities.
Chris Pudney (University of Bath)
QUBES monitors antibody stability and structure and is faster and more sensitive than existing approaches.
Jim Trimmer (University of California at Davis)
The UC Davis/NIH NeuroMab Facility and antibody validation for neuroscience research.
John Colyer (Badrilla)
Tools to assess the analytic performance of research antibodies.
Susanne Gräslund (Structural Genomics Consortium):
A general mass spectrometry-based method to determine the quality of novel antibodies in immunoprecipitation.
More talks will be uploaded as they become available.